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A 60-year-old woman presented with a dry cough without dyspnea or wheezing. Chest CT showed an
image of mucoid impactions, which were identiﬁed as mucoid impactions by bronchoﬁberscopy.
Aspergillus niger was cultured from her mucus. Her serum total IgE was 5150 IU/ml. Precipitins and IgE
speciﬁc for Aspergillus were positive. She had no history of asthma and no evidence of bronchocon-
striction by pulmonary function tests. Thus, a diagnosis was made of allergic bronchopulmonary
aspergillosis without asthma. She refused to take oral corticosteroids, although she improved sponta-
neously. However, her dry cough persisted. Her cough was relieved by administering an inhaled b-2
agonist; therefore, cough variant asthma was diagnosed. She was treated with an inhaled corticosteroid
and her cough resolved completely.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic
pulmonary disorder caused by a hypersensitivity reaction to anti-
gens of Aspergillus species. In general, an oral steroid is necessary to
treat ABPA.1 Bronchial asthma has been considered an essential
diagnostic criterion for ABPA. However, several cases without
bronchial asthma have been reported.2 We report a case of ABPA
presenting with cough variant asthmawith spontaneous remission.2. Case report
A 60-year-old woman presented with a 2-week history of dry
cough without dyspnea or wheezing. She was a housewife, a non-
smoker, and had no history of childhood asthma. She was afebrile
and her chest was clear on auscultation. A chest radiograph showed
bilateral inﬁltrates (Fig. 1). Laboratory ﬁndings showed a total
leukocyte count of 8200 cells/mm3 with 65.4% neutrophils and 3.0%
eosinophils, andaC-reactiveproteinconcentrationof2.51mg/dl. She
was diagnosed with pneumonia and administrated azithromycin.
Oneweek later, a chest CTshowedan imageofmucoid impactions
in the right middle lung lobe and the left lingular bronchus (Fig. 2a).
These were identiﬁed as mucoid impactions by bronchoﬁberscopy: þ81 78 261 6726.
atsuoka).
rved.(Fig. 3). Aspergillus niger was cultured from mucus aspirated by
bronchoﬁberscopy.
Her serum total IgE was 5150 IU/ml. IgE speciﬁc for Aspergillus
was positive by ELISA. Precipitins to Aspergillus were also positive.
Spirometry was normal with an FVC of 2.22 L (94% of predicted),
FEV1 of 2.03 L (103% of predicted), FEV1/FVC ratio of 91%, and no
changes after administering a bronchodilator. Peak expiratory ﬂow
variability was 6%. A provisional diagnosis of ABPAwithout asthma
was made.
She refused recommendations to take oral corticosteroids;
however, the inﬁltrates seen on chest radiography gradually
improvedwithout the use of oral corticosteroids. Twomonths later,
her serum IgE decreased to 2670 IU/ml, which was considered as
a state of remission. Chest CT showed bronchiectasis in the lingula
of the left lung, and the images of mucoid impaction had dis-
appeared (Fig. 2b). However, her dry cough persisted. Her exhaled
nitric oxide (ENO) was 77 ppb, and her cough was relieved by
administering an inhaled b-2 agonist; therefore, cough variant
asthma was diagnosed. She was treated with an inhaled cortico-
steroid and her cough resolved completely.
3. Discussion
ABPA is an allergic pulmonary disorder caused by a hypersensi-
tivity reaction to antigens of Aspergillus species. In general, an oral
steroid is necessary to treat ABPA.1 Bronchial asthma has been
considered an essential diagnostic criterion for ABPA. However,
Fig. 3. Bronchoﬁberscopy ﬁndings. Mucoid impaction in the right middle lung lobe
bronchus (B5b).Fig. 1. Chest radiograph showing bilateral inﬁltrates.
Fig. 2. a: Chest CT image during the acute phase shows an image of mucoid impactions
in the right middle lung lobe and the left lingular bronchus. b: Chest CT image during
the remission stage shows bronchiectasis in the lingula of the left lung. The image of
mucoid impactions has disappeared.
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knowledge, this is the ﬁrst case of ABPA presenting with cough
variant asthma that showed spontaneous remission without the
use of oral corticosteroids.
Cough variant asthma is an asthma phenotype that presents
solely with coughing. It involves airway eosinophilic inﬂammation,
as does classic asthma with wheezing. About 30% of these patients
may progress to classic asthma, which can be prevented by treat-
ment with an inhaled corticosteroid.3 A diagnosis of cough variant
asthma can bemade when all of the following are present: (i) cough
without wheezing lasting 8 weeks (or 3 weeks or more) and no
wheezing heard on auscultation; and (ii) relief of cough with bron-
chodilator therapy.3 All of these criteria were satisﬁed in the present
case. In addition, in the present case, ENOwas elevated (77 ppb). ENO
reﬂects airway eosinophilic inﬂammation and is useful for differen-
tiating cough variant asthma from other causes of chronic cough.4,5
Several cases of ABPA without bronchial asthma have been
reported.2,6 However, in those reports, some patients developed
bronchial asthma after the initial diagnosis.2 In those cases,
elevated sputum eosinophils or increased airway responsiveness
were found in some patients,2,7 which suggested that cough variant
asthma patients might have been included. Oral steroid use can
mask the cough due to cough variant asthma.8 In ABPA patients
with cough variant asthma, cough variant asthma may progress to
classic asthma after stopping or during the tapering of oral corti-
costeroids. Thus, in the case of ABPA without asthma, further
examination should be performed to rule out cough variant
asthma. And, if cough variant asthma is present, treatment with an
inhaled corticosteroid should be considered.
In general, an oral steroid is necessary to treat ABPA1; however,
the present case improved spontaneously without using an oral
steroid. She is being treated now only with an inhaled corticoste-
roid and has had no relapse. In this case, the peripheral eosinophil
count did not increase, which might indicate a mild form of ABPA.9
Some reports have suggested that an inhaled corticosteroid could
achieve adequate control of ABPA.10 However, relapse can occur.
Thus, these cases should be closely followed and treated with oral
steroids, as required.
H. Matsuoka et al. / Respiratory Medicine CME 4 (2011) 175e177 177In conclusion, in the case of ABPA without asthma, further
examination should be performed to rule out cough variant asthma.
Mild form of ABPA may improve without oral steroid therapy.
Conﬂict of interest
The authors have no conﬂict of interest.
References
1. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805e26.
2. Glancy JJ, Elder JL, McAleer R. Allergic bronchopulmonary fungal disease
without clinical asthma. Thorax 1981;36:345e9.
3. Kohno S, Ishida T, Uchida Y, et al. The Japanese Respiratory Society guidelines
for management of cough. Respirology 2006;4(Suppl. 11):S135e86.4. Fujimura M, Ohkura N, Abo M, et al. Exhaled nitric oxide levels in patients with
atopic cough and cough variant asthma. Respirology 2008;13:359e64.
5. Lim KG. Nitric oxide measurement in chronic cough. Lung 2010;1(Suppl.
188):S19e22.
6. Hoshino H, Tagaki S, Kon H, et al. Allergic bronchopulmonary aspergillosis due
to Aspergillus niger without bronchial asthma. Respiration 1999;66:369e72.
7. Yoshida N, Suguro H, Kohara F, et al. A case of allergic bronchopulmonary
aspergillosis with no history of bronchial asthma. Nihon Kyobu Shikkan Gakkai
Zasshi 1992;30:2123e7.
8. Krasnick J, Patterson R, Roberts M. Allergic bronchopulmonary aspergillosis
presenting with cough variant asthma and identiﬁable source of Aspergillus
fumigatus. Ann Allergy Asthma Immunol 1995;75:344e6.
9. Kiely JL, Spense L, Henry M, Hurley MF, Kelleher N, Bredin CP. Chest radio-
graphic staging in allergic bronchopulmonary aspergillosis: relationship with
immunological ﬁndings. Eur Respir J 1998;12:453e6.
10. Imbeault B, Cormier Y. Usefulness of inhaled high-dose corticosteroids in
allergic bronchopulmonary aspergillosis. Chest 1993;103:1614e7.
